Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study
Journal of the European Academy of Dermatology and Venereology · 2024-12 · 38 (12) · 2240-2249
DOI: 10.1111/jdv.19905 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 27.02.2024. Verfasst von Elisabeth Victoria Goessinger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Artificial Intelligence, Dermatologists, Early Detection of Cancer, Melanoma. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Universitätsspital Basel, Universität Basel.
Abstract (Originalsprache)
Background
Artificial intelligence (AI) shows promising potential to enhance human decision‐making as synergistic augmented intelligence (AuI), but requires critical evaluation for skin cancer screening in a real‐world setting.
Objectives
To investigate the perspectives of patients and dermatologists after skin cancer screening by human, artificial and augmented intelligence.
Methods
A prospective comparative cohort study conducted at the University Hospital Basel included 205 patients (at high‐risk of developing melanoma, with resected or advanced disease) and 8 dermatologists. Patients underwent skin cancer screening by a dermatologist with subsequent 2D and 3D total‐body photography (TBP). Any suspicious and all melanocytic skin lesions ≥3 mm were imaged with digital dermoscopes and classified by corresponding convolutional neural networks (CNNs). Excisions were performed based on dermatologist's melanoma suspicion, study‐defined elevated CNN risk‐scores and/or melanoma suspicion by AuI. Subsequently, all patients and dermatologists were surveyed about their experience using questionnaires, including quantification of patient's safety sense following different examinations (subjective safety score (SSS): 0–10).
Results
Most patients believed AI could improve diagnostic performance (95.5%, n = 192/201). In total, 83.4% preferred AuI‐based skin cancer screening compared to examination by AI or dermatologist alone (3D‐TBP: 61.3%; 2D‐TBP: 22.1%, n = 199). Regarding SSS, AuI induced a significantly higher feeling of safety than AI (mean‐SSS (mSSS): 9.5 vs. 7.7, p < 0.0001) or dermatologist screening alone (mSSS: 9.5 vs. 9.1, p = 0.001). Most dermatologists expressed high trust in AI examination results (3D‐TBP: 90.2%; 2D‐TBP: 96.1%, n = 205). In 68.3% of the examinations, dermatologists felt that diagnostic accuracy improved through additional AI‐assessment ( n = 140/205). Especially beginners (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Basel, Basel, Switzerland.
- Faculty of Medicine, University of Basel, Basel, Switzerland.
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- Faculty of Medicine, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Elisabeth Victoria Goessinger, Sara Cerminara, Julia-Tatjana Maul, Alexander Navarini, Lara Valeska Maul
Förderung
- Universitätsspital Basel
- Universität Basel
Zitieren
APA
Goessinger, E. V., Niederfeilner, J. C., Cerminara, S., Maul, J. T., Kostner, L., Kunz, M., Huber, S., Koral, E., Habermacher, L., Sabato, G., Tadic, A., Zimmermann, C., Navarini, A., & Maul, L. V. (2024). Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study. Journal of the European Academy of Dermatology and Venereology, 38(12), 2240-2249. https://doi.org/10.1111/jdv.19905
Vancouver
Goessinger EV, Niederfeilner JC, Cerminara S, Maul JT, Kostner L, Kunz M, et al. Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study. Journal of the European Academy of Dermatology and Venereology. 2024;38(12):2240-2249. doi:10.1111/jdv.19905
BibTeX
@article{Goessinger2024,
author = {Goessinger, Elisabeth Victoria and Niederfeilner, Johannes-Christian and Cerminara, Sara and Maul, Julia-Tatjana and Kostner, Lisa and Kunz, Michael and Huber, Stephanie and Koral, Emrah and Habermacher, Lea and Sabato, Gianna and Tadic, Andrea and Zimmermann, Carmina and Navarini, Alexander and Maul, Lara Valeska},
title = {Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
volume = {38},
number = {12},
pages = {2240--2249},
doi = {10.1111/jdv.19905}
}
EUVIMED